2015 Life Sciences Outlook Japan

• Autorzy: Jun Matsuo
• Języki publikacji: EN

Abstrakty

EN

The Japanese pharmaceutical market is the world's second-largest, with 2013 sales estimated at $115 billion. Japan accounts for a little less than 10 percent of the global pharma market, compared with 38.4 percent for the U.S. and 20.7 percent for Western Europe [Industry Report 2014], Japan's rapidly aging population-just over a quarter of the population was aged 65+ in 2013, up from 12 percent in 1990, and this age group accounts for over 50 percent of the country's health care costs [Industry Report 2014] - is expected to drive demand for pharmaceuticals in 2014- 2018. However, modest economic growth, drug price cuts, and pro-generics policies will likely keep pharma revenue increases in check - growth is expected to average 2.2 percent annually, with revenues totaling $128 billion 2018. (fragment of text)

Słowa kluczowe

EN

Pharmaceutical market; Pharmaceutical industry; Development

PL

Rynek farmaceutyczny; Przemysł farmaceutyczny; Rozwój

• Czasopismo: Czasopismo "Ekonomia i Zarządzanie"
• Rocznik: 2015
• Numer: nr 6
• Strony: 58--59

Twórcy

autor

Jun Matsuo

• Deloitte Japan

Bibliografia

• Industry Report, 2014, Healthcare: Japan, The Economist Intelligence Unit, June.
• MR Education & Accreditation Center of Japan.